Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors
1. CATX appointed Maya Martinez-Davis as an independent director. 2. Martinez-Davis has extensive experience in oncology from GSK and Merck. 3. The appointment aims to enhance shareholder value and advance clinical programs. 4. CATX is developing innovative radiopharmaceutical treatments for various cancers. 5. The company’s proprietary technology utilizes alpha-emitting isotopes for targeted treatment.